Healthcare
Live Price
Offline$2.11
+1.44% today
1Y Change
-26.47%
Window
Jun 23, 2025 → Jun 3, 2026
Coverage: 238 bars · Jun 23, 2025 → Jun 3, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sintx Technologies, Inc. (SINT) is a Healthcare stock with a market cap of $10.00M and listed on NASDAQ. The stock last traded around $2.11 and down 26.5% across the available one-year price window (Jun 23, 2025 → Jun 3, 2026). Baseline metrics include revenue growth of -18.3%, EPS growth of +58.6%, a dividend yield of 0.0%. What stands out right now is revenue -18.3%, EPS +58.6%, free cash flow +6.2% with operating margin -1053.1% and ROIC -173.7%. Valuation sits in the middle of the pack at price/sales 6.6. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SINT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SINT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SINT Max Drawdown
-63.88%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SINT and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$606.0K
+0.8% YoY
FY Net Income
-$9.3M
+22.7% YoY
Free Cash Flow
-$13.9M
-18.9% YoY
Revenue Growth
-18.3%
EPS Growth
+58.6%
Gross Margin
-19.7%
Net Margin
-1678.1%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1M | 1M | 3M | 601K | 606K |
| Gross Profit | -201K | 435K | 2M | 336K | 157K |
| Operating Income | -11M | -14M | -13M | -11M | -11M |
| EBITDA | -10M | -10M | -7M | -11M | -9M |
| Net Income | -17M | -11M | -8M | -12M | -9M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 4M | 4M | 3M | 6M | 14M |
| Total Assets | 10M | 9M | 15M | 16M | 22M |
| Total Liabilities | 7M | 6M | 7M | 10M | 5M |
| Shareholder Equity | 3M | 4M | 9M | 6M | 17M |
| Total Debt | 3M | 4M | 5M | 4M | 3M |
| Net Debt | -898K | 427K | 1M | -3M | -11M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
10M
+1.3% YoY
Capital Expenditures
4M
-166.5% YoY
Free Cash Flow
14M
-18.9% YoY
Key ratios
Gross Margin
-19.7%
Operating Margin
-1053.1%
Net Margin
-1678.1%
ROE
-400.1%
Debt / Equity
1.11x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.